Skip Navigation

Cardiovascular Research 1999 41(2):465-472; doi:10.1016/S0008-6363(98)00304-6
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Depre, C.
Right arrow Articles by Wijns, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Depre, C.
Right arrow Articles by Wijns, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque

Christophe Deprea,*, Xavier Havauxa, Jean Renkina, Jean Louis J. Vanoverscheldea and William Wijnsb

aDivision of Cardiology, University of Louvain Medical School, Brussels, Belgium
bCardiovascular Center, OLV Ziekenhuis Aalst, Belgium

* Address for correspondence: Division of Cardiology, University of Texas Houston Medical Center, 6431 Fannin, MSB 1.608, Houston, TX 77030. Tel.: +1-713-500-6571; fax: +1-713-500-6556.

Objective: Macrophages in atherosclerotic plaque may express the inducible isoform of NO synthase (iNOS), which produces large amounts of NO. On one hand, the production of NO can be protective by its vasodilatory, antiaggregant and antiproliferative effects. On the other hand, the formation of peroxynitrite from NO may favour vasospasm and thrombogenesis. In this study, we investigated whether iNOS is present in human coronary atherosclerotic plaque, and we correlated these data with the clinical instability of the patients. Methods: Fragments were retrieved by coronary atherectomy from 24 patients with unstable angina and 12 patients with stable angina. The presence of macrophages, and the production of TNF{alpha}, iNOS and nitrotyrosine were detected by immunocytochemistry. Results: Macrophage clusters were found in 67% of stable patients and 87% of patients with unstable angina (NS). TNF{alpha} was expressed in about 50% of cases in both groups. iNOS was not expressed in fragments from stable patients but was found in macrophages from 58% of unstable patients (P<0.001). The expression of iNOS was associated with the presence of nitrotyrosine residues, a marker of peroxynitrite formation. Expression of iNOS was correlated both with complaints of angina at rest (P<0.05) and with the presence of thrombus at morphological examination (P<0.001). Conclusion: The expression of iNOS may be induced in human coronary atherosclerotic plaque and is associated with different factors of instability.

KEYWORDS Atherosclerosis; Cytokines; Macrophage; Nitric oxide; Unstable angina


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Schmidt, T. H. Westhoff, P. Krauser, W. Zidek, and M. van der Giet
The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. G. Nielsen, J. P. Crow, F. Zhou, and D. A. Parks
Peroxynitrite Inactivates Tissue Plasminogen Activator
Anesth. Analg., May 1, 2004; 98(5): 1312 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. V. Turko and F. Murad
Protein Nitration in Cardiovascular Diseases
Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Borkowski, B. R. Younge, L. Szweda, B. Mock, J. Bjornsson, K. Moeller, J. J. Goronzy, and C. M. Weyand
Reactive Nitrogen Intermediates in Giant Cell Arteritis : Selective Nitration of Neocapillaries
Am. J. Pathol., July 1, 2002; 161(1): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. M. Lincoln, N. Dey, and H. Sellak
Signal Transduction in Smooth Muscle: Invited Review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression
J Appl Physiol, September 1, 2001; 91(3): 1421 - 1430.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
U. Ikeda, M. Shimpo, Y. Murakami, and K. Shimada
Peroxisome Proliferator-Activated Receptor-{gamma} Ligands Inhibit Nitric Oxide Synthesis in Vascular Smooth Muscle Cells
Hypertension, June 1, 2000; 35(6): 1232 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Yang, D. F. Larson, and R. Watson
Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1906 - H1913.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C.-L. M. Cooke and S. T. Davidge
Peroxynitrite increases iNOS through NF-kappa B and decreases prostacyclin synthase in endothelial cells
Am J Physiol Cell Physiol, February 1, 2002; 282(2): C395 - C402.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.